ORACLE INVESTMENT MANAGEMENT INC - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 83 filers reported holding REPROS THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
ORACLE INVESTMENT MANAGEMENT INC ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q3 2014$10,040,000
-100.0%
1,014,164
-20.0%
1.39%
-47.8%
Q2 2014$21,921,280,000
-0.5%
1,267,126
+2.0%
2.66%
+5.7%
Q1 2014$22,038,863,0001,242,3262.52%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Sarissa Capital Management LP 1,132,367$9,727,0002.05%
RTW INVESTMENTS, LP 229,364$1,970,0000.89%
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC 361,300$3,104,0000.85%
DESTRIER CAPITAL MANAGEMENT LLC 329,030$2,826,0000.73%
SENZAR ASSET MANAGEMENT, LLC 244,006$2,096,0000.51%
GENERAL AMERICAN INVESTORS CO INC 508,375$4,367,0000.36%
CQS Cayman LP 700,000$6,013,0000.28%
Rotella Capital Management, Inc. 20,800$179,0000.15%
Baker Brothers Advisors 2,000,000$17,180,0000.14%
Gruss Capital Management LP 304,000$2,611,0000.11%
View complete list of REPROS THERAPEUTICS INC shareholders